Integral Health Asset Management, LLC Nektar Therapeutics Transaction History

Integral Health Asset Management, LLC

  • $1.06 Billion
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$14.47 - $27.96 $1.09 Million - $2.1 Million
-75,000 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$15.87 - $23.12 $1.19 Million - $1.73 Million
75,000 New
75,000 $1.62 Million

Others Institutions Holding NKTR

# of Institutions
128
Shares Held
111M
Call Options Held
150K
Put Options Held
4K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $231M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Integral Health Asset Management, LLC Portfolio

Follow Integral Health Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integral Health Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email